ID   MHCC97H-GFP-LC3
AC   CVCL_A9LY
DR   cancercelllines; CVCL_A9LY
DR   CCRID; 4201PAT-CCTCC00404
DR   Wikidata; Q108820908
RX   Patent=CN102115730A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201097.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6838; MAP1LC3A.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4972 ! MHCC97-H
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
RX   Patent=CN102115730A;
RA   Fan, Jia
RA   Shi, Ying-Hong
RA   Peng, Yuan-Fei
RA   Ding, Zhen-Bin
RT   "High metastatic potential hepatoma cell line capable of steady
RT   autophagy indication, and establishment method and application method
RT   thereof.";
RL   Patent number CN102115730A, 06-Jul-2011.
//